PIMA541973
Lirilumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA541973-Each-of-1 | In Stock | ₹ 44,020.62 |
PIMA541973 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,020.62
GST (18%): ₹ 7,923.712
Total Price: ₹ 51,944.332
Antigen
Lirilumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
BMS-986015; IPH2102
Immunogen
Human KIRD2 subgroup
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
0.79 mg/mL
Formulation
PBS with no preservative; pH 7.4
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG1
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Lirilumab has been used in trials studying the treatment of Leukemia, CANCER, NOS, Multiple Myeloma, Lymphocytic Leukemia, and Acute Myeloid Leukemia, among others.
Compare Similar Items
Show Difference
Antigen: Lirilumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: BMS-986015; IPH2102
Immunogen: Human KIRD2 subgroup
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 0.79 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1
Antigen:
Lirilumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
BMS-986015; IPH2102
Immunogen:
Human KIRD2 subgroup
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
0.79 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1
Antigen: Nivolumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: BMS-936558; MDX-1106; ONO-4538; Opdivo
Immunogen: Human PDCD1/PD1/CD279
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.3 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG4 κ
Antigen:
Nivolumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
BMS-936558; MDX-1106; ONO-4538; Opdivo
Immunogen:
Human PDCD1/PD1/CD279
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.3 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG4 κ
Antigen: Perakizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: RG4934; RO5310074
Immunogen: Human IL17A
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.84 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Perakizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
RG4934; RO5310074
Immunogen:
Human IL17A
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.84 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Modotuximab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: DS 1024; ERBB1 domain III; Sym 004 (combination of modotuximab and futuximab)
Immunogen: Human EGFR/ERBB1 domain III
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Modotuximab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
DS 1024; ERBB1 domain III; Sym 004 (combination of modotuximab and futuximab)
Immunogen:
Human EGFR/ERBB1 domain III
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ